Estimating Dead-Space Fraction for Secondary Analyses of Acute Respiratory Distress Syndrome Clinical Trials

Critical Care Medicine - United States
doi 10.1097/ccm.0000000000000921
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Clinical Features of Acute Lung Injury and Acute Respiratory Distress Syndrome

Folia Pharmacologica Japonica
Pharmacology
2011English

Surfactant Treatment for Acute Respiratory Distress Syndrome

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1999English

Pathogenesis of Acute Respiratory Distress Syndrome

Seminars in Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2019English

Surfactant Medication for Acute Respiratory Distress Syndrome

Thorax
PulmonaryRespiratory Medicine
1997English

Pathogenesis of Acute Respiratory Distress Syndrome

Obshchaya Reanimatologiya
Critical CareIntensive Care Medicine
2012English

Treatment of Acute Respiratory Distress Syndrome in Secondary Surfactant Deficiency in Neonates

Paediatrica Indonesiana
2007English

Lung-Protective Ventilation for Acute Respiratory Distress Syndrome

Academic Emergency Medicine
MedicineEmergency Medicine
2018English

Clinical Outcomes of Acute Respiratory Distress Syndrome in a University Hospital

Asian Biomedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Corticosteroids and Acute Respiratory Distress Syndrome

Critical Care Medicine
Critical CareIntensive Care Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy